Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'

Andrés J M Ferreri, Elías Campo, John F. Seymour, Rein Willemze, Fiorella Ilariucci, Achille Ambrosetti, Emanuele Zucca, Giuseppe Rossi, Armando López-Guillermo, Miguel A. Pavlovsky, Marie Louise Geerts, Anna Candoni, Maurizio Lestani, Silvia Asioli, Mario Milani, Miguel A. Piris, Stefano Pileri, Fabio Facchetti, Franco Cavalli, Maurilio Ponzoni

Research output: Contribution to journalArticle

Abstract

Despite its recognition as a distinct, extremely rare entity, no large studies of intravascular lymphoma (IVL) have been reported. The clinico-pathological characteristics of 38 human immunodeficiency virus-negative patients with IVL diagnosed in Western countries were reviewed to better delineate clinical presentation, clinical variants, natural history and optimal therapy. The IVL is an aggressive and usually disseminated disease (Ann Arbor stage IV in 68% of cases) that predominantly affects elderly patients (median age 70 years, range: 34-90; male:female ratio 0.9), resulting in poor Eastern Cooperative Oncology Group Performance Status (ECOG-PS >1 in 61%), B symptoms (55%), anaemia (63%) and high serum lactate dehydrogenase level (86%). The brain and skin are the most common sites of disease. In contrast to previous reports, hepatosplenic involvement (26%) and bone marrow infiltration (32%) were found to be common features in IVL, while nodal disease was confirmed as rare (11% of cases). Patients with disease limited to the skin ('cutaneous variant'; 26% of cases) were invariably females with a normal platelet count, and exhibited a significantly better outcome than the remaining patients, which deserves further investigation. Overall survival was usually poor; however, the early use of intensive therapies could improve outcome in young patients with unfavourable features. ECOG-PS >1, 'cutaneous variant', stage I and chemotherapy use were independently associated with improved survival.

Original languageEnglish
Pages (from-to)173-183
Number of pages11
JournalBritish Journal of Haematology
Volume127
Issue number2
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Natural History
Lymphoma
Skin
Survival
Platelet Count
L-Lactate Dehydrogenase
Anemia
Bone Marrow
HIV
Drug Therapy
Brain
Therapeutics
Serum

Keywords

  • Angiotropic lymphoma
  • Central nervous system lymphomas
  • Cutaneous lymphoma
  • Extranodal lymphoma
  • Intravascular lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Intravascular lymphoma : Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. / Ferreri, Andrés J M; Campo, Elías; Seymour, John F.; Willemze, Rein; Ilariucci, Fiorella; Ambrosetti, Achille; Zucca, Emanuele; Rossi, Giuseppe; López-Guillermo, Armando; Pavlovsky, Miguel A.; Geerts, Marie Louise; Candoni, Anna; Lestani, Maurizio; Asioli, Silvia; Milani, Mario; Piris, Miguel A.; Pileri, Stefano; Facchetti, Fabio; Cavalli, Franco; Ponzoni, Maurilio.

In: British Journal of Haematology, Vol. 127, No. 2, 10.2004, p. 173-183.

Research output: Contribution to journalArticle

Ferreri, AJM, Campo, E, Seymour, JF, Willemze, R, Ilariucci, F, Ambrosetti, A, Zucca, E, Rossi, G, López-Guillermo, A, Pavlovsky, MA, Geerts, ML, Candoni, A, Lestani, M, Asioli, S, Milani, M, Piris, MA, Pileri, S, Facchetti, F, Cavalli, F & Ponzoni, M 2004, 'Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'', British Journal of Haematology, vol. 127, no. 2, pp. 173-183. https://doi.org/10.1111/j.1365-2141.2004.05177.x
Ferreri, Andrés J M ; Campo, Elías ; Seymour, John F. ; Willemze, Rein ; Ilariucci, Fiorella ; Ambrosetti, Achille ; Zucca, Emanuele ; Rossi, Giuseppe ; López-Guillermo, Armando ; Pavlovsky, Miguel A. ; Geerts, Marie Louise ; Candoni, Anna ; Lestani, Maurizio ; Asioli, Silvia ; Milani, Mario ; Piris, Miguel A. ; Pileri, Stefano ; Facchetti, Fabio ; Cavalli, Franco ; Ponzoni, Maurilio. / Intravascular lymphoma : Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. In: British Journal of Haematology. 2004 ; Vol. 127, No. 2. pp. 173-183.
@article{64cd54e30593460097b07a97476c597f,
title = "Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'",
abstract = "Despite its recognition as a distinct, extremely rare entity, no large studies of intravascular lymphoma (IVL) have been reported. The clinico-pathological characteristics of 38 human immunodeficiency virus-negative patients with IVL diagnosed in Western countries were reviewed to better delineate clinical presentation, clinical variants, natural history and optimal therapy. The IVL is an aggressive and usually disseminated disease (Ann Arbor stage IV in 68{\%} of cases) that predominantly affects elderly patients (median age 70 years, range: 34-90; male:female ratio 0.9), resulting in poor Eastern Cooperative Oncology Group Performance Status (ECOG-PS >1 in 61{\%}), B symptoms (55{\%}), anaemia (63{\%}) and high serum lactate dehydrogenase level (86{\%}). The brain and skin are the most common sites of disease. In contrast to previous reports, hepatosplenic involvement (26{\%}) and bone marrow infiltration (32{\%}) were found to be common features in IVL, while nodal disease was confirmed as rare (11{\%} of cases). Patients with disease limited to the skin ('cutaneous variant'; 26{\%} of cases) were invariably females with a normal platelet count, and exhibited a significantly better outcome than the remaining patients, which deserves further investigation. Overall survival was usually poor; however, the early use of intensive therapies could improve outcome in young patients with unfavourable features. ECOG-PS >1, 'cutaneous variant', stage I and chemotherapy use were independently associated with improved survival.",
keywords = "Angiotropic lymphoma, Central nervous system lymphomas, Cutaneous lymphoma, Extranodal lymphoma, Intravascular lymphoma",
author = "Ferreri, {Andr{\'e}s J M} and El{\'i}as Campo and Seymour, {John F.} and Rein Willemze and Fiorella Ilariucci and Achille Ambrosetti and Emanuele Zucca and Giuseppe Rossi and Armando L{\'o}pez-Guillermo and Pavlovsky, {Miguel A.} and Geerts, {Marie Louise} and Anna Candoni and Maurizio Lestani and Silvia Asioli and Mario Milani and Piris, {Miguel A.} and Stefano Pileri and Fabio Facchetti and Franco Cavalli and Maurilio Ponzoni",
year = "2004",
month = "10",
doi = "10.1111/j.1365-2141.2004.05177.x",
language = "English",
volume = "127",
pages = "173--183",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - Intravascular lymphoma

T2 - Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'

AU - Ferreri, Andrés J M

AU - Campo, Elías

AU - Seymour, John F.

AU - Willemze, Rein

AU - Ilariucci, Fiorella

AU - Ambrosetti, Achille

AU - Zucca, Emanuele

AU - Rossi, Giuseppe

AU - López-Guillermo, Armando

AU - Pavlovsky, Miguel A.

AU - Geerts, Marie Louise

AU - Candoni, Anna

AU - Lestani, Maurizio

AU - Asioli, Silvia

AU - Milani, Mario

AU - Piris, Miguel A.

AU - Pileri, Stefano

AU - Facchetti, Fabio

AU - Cavalli, Franco

AU - Ponzoni, Maurilio

PY - 2004/10

Y1 - 2004/10

N2 - Despite its recognition as a distinct, extremely rare entity, no large studies of intravascular lymphoma (IVL) have been reported. The clinico-pathological characteristics of 38 human immunodeficiency virus-negative patients with IVL diagnosed in Western countries were reviewed to better delineate clinical presentation, clinical variants, natural history and optimal therapy. The IVL is an aggressive and usually disseminated disease (Ann Arbor stage IV in 68% of cases) that predominantly affects elderly patients (median age 70 years, range: 34-90; male:female ratio 0.9), resulting in poor Eastern Cooperative Oncology Group Performance Status (ECOG-PS >1 in 61%), B symptoms (55%), anaemia (63%) and high serum lactate dehydrogenase level (86%). The brain and skin are the most common sites of disease. In contrast to previous reports, hepatosplenic involvement (26%) and bone marrow infiltration (32%) were found to be common features in IVL, while nodal disease was confirmed as rare (11% of cases). Patients with disease limited to the skin ('cutaneous variant'; 26% of cases) were invariably females with a normal platelet count, and exhibited a significantly better outcome than the remaining patients, which deserves further investigation. Overall survival was usually poor; however, the early use of intensive therapies could improve outcome in young patients with unfavourable features. ECOG-PS >1, 'cutaneous variant', stage I and chemotherapy use were independently associated with improved survival.

AB - Despite its recognition as a distinct, extremely rare entity, no large studies of intravascular lymphoma (IVL) have been reported. The clinico-pathological characteristics of 38 human immunodeficiency virus-negative patients with IVL diagnosed in Western countries were reviewed to better delineate clinical presentation, clinical variants, natural history and optimal therapy. The IVL is an aggressive and usually disseminated disease (Ann Arbor stage IV in 68% of cases) that predominantly affects elderly patients (median age 70 years, range: 34-90; male:female ratio 0.9), resulting in poor Eastern Cooperative Oncology Group Performance Status (ECOG-PS >1 in 61%), B symptoms (55%), anaemia (63%) and high serum lactate dehydrogenase level (86%). The brain and skin are the most common sites of disease. In contrast to previous reports, hepatosplenic involvement (26%) and bone marrow infiltration (32%) were found to be common features in IVL, while nodal disease was confirmed as rare (11% of cases). Patients with disease limited to the skin ('cutaneous variant'; 26% of cases) were invariably females with a normal platelet count, and exhibited a significantly better outcome than the remaining patients, which deserves further investigation. Overall survival was usually poor; however, the early use of intensive therapies could improve outcome in young patients with unfavourable features. ECOG-PS >1, 'cutaneous variant', stage I and chemotherapy use were independently associated with improved survival.

KW - Angiotropic lymphoma

KW - Central nervous system lymphomas

KW - Cutaneous lymphoma

KW - Extranodal lymphoma

KW - Intravascular lymphoma

UR - http://www.scopus.com/inward/record.url?scp=5644239684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644239684&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.05177.x

DO - 10.1111/j.1365-2141.2004.05177.x

M3 - Article

C2 - 15461623

AN - SCOPUS:5644239684

VL - 127

SP - 173

EP - 183

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -